CARENCT07010445
MiCrobiota-gut-brain Axis in Resistant Epilepsy
At risk: Primary completion moved at least 6 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Aug 2026 to Feb 28, 2027 Show 5 more changesShow less
- Eligibility criteria expanded, about 7 words
- Study completion date: Feb 2027 to Feb 28, 2027
- Secondary endpoints: details revised at 1 of 3 entries
- Study description shortened, about 6 words
- Publications: details revised at 1 of 1 entry
- Minor Interventions: Naïve: epilepsy first diagnosis, anti-epileptic drugs; DRE-surgery: resective surgery; DRE-VNS: vagal nerve stimulation; DRE-KD: ketogenic… to DRE-KD: ketogenic diet. (Other), DRE-VNS: vagal nerve stimulation; (Other), DRE-surgery: resective surgery; (Other), Naïve: epilepsy first…
- Secondary endpoints: details revised at 1 of 3 entries
- Study arms: 4 to 5
- Study description shortened, about 1 word
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Gut Microbiota Changes
Timeframe: 1 - 6 - 12 months
Gut Microbiota Biomarkers
Timeframe: 1,6, and 12 months
Secondary (3)
Quality of Life
Gastrointestinal health
Methylation Level
Arms and interventions
NaïveOther
Subjects at the seizure onset (Naïve)
DRE-surgeryOther
DRE undergoing resective surgery (DRE-surgery)
DRE-VNSOther
DRE undergoing vagal nerve stimulation (DRE-VNS)
DRE-KDOther
DRE on diet therapy (Ketogenic diet).
anti-epileptic drugs;Other
anti-epileptic drugs;
Other: Naïve: epilepsy first diagnosis,, DRE-surgery: resective surgery;, DRE-VNS: vagal nerve stimulation;, DRE-KD: ketogenic diet.
Drugs: anti-epileptic drugs;
Sites
1 site in 1 country
- ASST GOM NiguardaMilan, Lombardy, Italy